The breast cancer cell lines further split into two groups, which corresponded to their HER2 status—an important prognostic marker based on the assessment of the expression level of the epidermal growth factor receptor 2 (HER2/EGFR) [21,22]. The gene discussed is ERBB2; the disease is breast carcinoma.